Suppr超能文献

从胚胎干细胞到诱导多能干细胞——准备好临床治疗了吗?

From embryonic stem cells to induced pluripotent stem cells-Ready for clinical therapy?

机构信息

Department of Neonatology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

出版信息

Clin Transplant. 2019 Jun;33(6):e13573. doi: 10.1111/ctr.13573. Epub 2019 May 12.

Abstract

Embryonic stem cells and induced pluripotent stem cells have increasingly important roles in many different fields of research and medicine. Major areas of impact include improved in vitro disease models, drug screening, and the development of cell-based clinical therapies. Here, we review the generation and uses of embryonic stem cells compared to induced pluripotent stem cells and discuss their advantages and limitations. We also evaluate the feasibility of clinical therapies and the future prospects for induced pluripotent cell-based treatments.

摘要

胚胎干细胞和诱导多能干细胞在许多不同的研究和医学领域中发挥着越来越重要的作用。主要影响领域包括改进体外疾病模型、药物筛选和基于细胞的临床治疗方法的开发。在这里,我们比较了胚胎干细胞和诱导多能干细胞的产生和用途,并讨论了它们的优缺点。我们还评估了临床治疗的可行性和诱导多能细胞治疗的未来前景。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验